AbbVie affirms FY2026 adjusted EPS guidance at $13.87-$14.07
AbbVie affirms FY2026 adjusted EPS guidance of $13.87-$14.07 versus a $14.08 analyst estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.